![American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy | Circulation American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy | Circulation](https://www.ahajournals.org/cms/asset/d3fb81f9-6ff6-4f4e-b74b-fda275ece26a/01.cir.0000063575.17904.4e.fp.png)
American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy | Circulation
![Frontiers | Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy Frontiers | Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy](https://www.frontiersin.org/files/Articles/729359/fimmu-12-729359-HTML/image_m/fimmu-12-729359-g001.jpg)
Frontiers | Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy
![The Anti-Inflammatory Agent Bindarit Attenuates the Impairment of Neural Development through Suppression of Microglial Activation in a Neonatal Hydrocephalus Mouse Model | Journal of Neuroscience The Anti-Inflammatory Agent Bindarit Attenuates the Impairment of Neural Development through Suppression of Microglial Activation in a Neonatal Hydrocephalus Mouse Model | Journal of Neuroscience](https://www.jneurosci.org/sites/default/files/highwire/jneuro/42/9.cover-source.jpg)
The Anti-Inflammatory Agent Bindarit Attenuates the Impairment of Neural Development through Suppression of Microglial Activation in a Neonatal Hydrocephalus Mouse Model | Journal of Neuroscience
![Deferoxamine mesylate improves splicing and GAA activity of the common c.-32-13T>G allele in late-onset PD patient fibroblasts: Molecular Therapy - Methods & Clinical Development Deferoxamine mesylate improves splicing and GAA activity of the common c.-32-13T>G allele in late-onset PD patient fibroblasts: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/4d5baea7-4a01-4817-aced-3230bedfe1d1/fx1_lrg.jpg)
Deferoxamine mesylate improves splicing and GAA activity of the common c.-32-13T>G allele in late-onset PD patient fibroblasts: Molecular Therapy - Methods & Clinical Development
Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application | Journal of Medicinal Chemistry
![IJMS | Free Full-Text | Stimulating Mitochondrial Biogenesis with Deoxyribonucleosides Increases Functional Capacity in ECHS1-Deficient Cells IJMS | Free Full-Text | Stimulating Mitochondrial Biogenesis with Deoxyribonucleosides Increases Functional Capacity in ECHS1-Deficient Cells](https://www.mdpi.com/ijms/ijms-23-12610/article_deploy/html/images/ijms-23-12610-g001.png)
IJMS | Free Full-Text | Stimulating Mitochondrial Biogenesis with Deoxyribonucleosides Increases Functional Capacity in ECHS1-Deficient Cells
![Therapy-Induced Changes of Gene Expression in a Matched Pair of Small Cell Lung Cancer (SCLC) Cell Lines Therapy-Induced Changes of Gene Expression in a Matched Pair of Small Cell Lung Cancer (SCLC) Cell Lines](https://www.scirp.org/html/paperimages/22322_8.jpg)
Therapy-Induced Changes of Gene Expression in a Matched Pair of Small Cell Lung Cancer (SCLC) Cell Lines
![Frontiers | International Prognostic Index-Based Immune Prognostic Model for Diffuse Large B-Cell Lymphoma Frontiers | International Prognostic Index-Based Immune Prognostic Model for Diffuse Large B-Cell Lymphoma](https://www.frontiersin.org/files/Articles/732006/fimmu-12-732006-HTML/image_m/fimmu-12-732006-g001.jpg)